This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (1) Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Hiraki, L.T. Articles by Silverman, E.D. Search for Related Content PubMed PubMed Citation Articles by Hiraki, L.T. Articles by Silverman, E.D. Social Bookmarking                         What's this?

Review: Measuring permanent damage in pediatric systemic lupus erythematosus

Division of Rheumatology, Hospital for Sick Children, University of Toronto, Toronto, Canada, Department of Pediatrics, Hospital for Sick Children, University of Toronto, Toronto, Canada

J. Hamilton

Endocrinology, Hospital for Sick Children, University of Toronto, Toronto, Canada, Department of Immunology, Hospital for Sick Children, University of Toronto, Toronto, Canada

E.D. Silverman

Division of Rheumatology, Hospital for Sick Children, University of Toronto, Toronto, Canada, earl.silverman{at}sickkids.ca, Department of Pediatrics, Hospital for Sick Children, University of Toronto, Toronto, Canada, Department of Immunology, Hospital for Sick Children, University of Toronto, Toronto, Canada

The survival rates in pediatric systemic lupus erythematosus (pSLE) have improved greatly over recent decades. Increased life expectancy has meant that more children are growing up with the consequences of chronic disease and prolonged therapy. Assessing complications of disease and its therapy becomes an important outcome measure by which to evaluate our therapeutic interventions and appraise quality of life.

In this paper we review the development of the Systemic Lupus International Collaborative Clinics (SLICC)/American College of Rheumatology (ACR) Damage Index (SDI) and its application to the pSLE population. We examine the profile of damage in pSLE as identified by the SDI. However we also critically appraise its application and identify potential limitations in the SDI as a measure of permanent disease damage in children. In this paper we put forth suggestions for additional domains addressing pediatric specific issues such as decreased final height and delayed puberty. We also suggest modifications to domains of gonadal failure, diabetes mellitus, cognitive impairment and osteonecrosis in the SDI to make it more reflective of the damage phenomenon observed in pediatrics. Lupus (2007) 16: 657—662.

Key Words: disease damage • outcome • pediatrics • systemic lupus erythematosus

Lupus, Vol. 16, No. 8, 657-662 (2007)
DOI: 10.1177/0961203307078975


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				J. Thornton, M. W. Beresford, and P. Clayton Improving the evidence base for treatment of juvenile idiopathic arthritis: the challenge and opportunity facing the MCRN/ARC Paediatric Rheumatology Clinical Studies Group Rheumatology, May 1, 2008; 47(5): 563 - 566. [Full Text] [PDF]